Search

Binu Thomas

Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )

Most Active Art Unit
1717
Art Unit(s)
1717
Total Applications
891
Issued Applications
585
Pending Applications
109
Abandoned Applications
239

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8324522 [patent_doc_number] => 20120196936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders' [patent_app_type] => utility [patent_app_number] => 13/497421 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8400 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497421 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/497421
Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders Sep 19, 2010 Abandoned
Array ( [id] => 7756783 [patent_doc_number] => 20120028931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'HETEROCYCLIC M-GLU5 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/882169 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47986 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028931.pdf [firstpage_image] =>[orig_patent_app_number] => 12882169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/882169
HETEROCYCLIC M-GLU5 ANTAGONISTS Sep 13, 2010 Abandoned
Array ( [id] => 5993563 [patent_doc_number] => 20110015216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Solid Pharmaceutical Dosage Form' [patent_app_type] => utility [patent_app_number] => 12/880781 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5805 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015216.pdf [firstpage_image] =>[orig_patent_app_number] => 12880781 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/880781
Solid pharmaceutical dosage form Sep 12, 2010 Issued
Array ( [id] => 6134528 [patent_doc_number] => 20110008430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Solid Pharmaceutical Dosage Form' [patent_app_type] => utility [patent_app_number] => 12/880766 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5804 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008430.pdf [firstpage_image] =>[orig_patent_app_number] => 12880766 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/880766
Solid pharmaceutical dosage form Sep 12, 2010 Issued
Array ( [id] => 6196672 [patent_doc_number] => 20110028430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/876474 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2007 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028430.pdf [firstpage_image] =>[orig_patent_app_number] => 12876474 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/876474
INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND Sep 6, 2010 Abandoned
Array ( [id] => 9140321 [patent_doc_number] => 08580783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => '[1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators' [patent_app_type] => utility [patent_app_number] => 13/394255 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22025 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394255 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/394255
[1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators Sep 2, 2010 Issued
Array ( [id] => 6026580 [patent_doc_number] => 20110054036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'COMPOSITION AND METHOD FOR IRRIGATION OF A PREPARED DENTAL ROOT CANAL' [patent_app_type] => utility [patent_app_number] => 12/868457 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4088 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054036.pdf [firstpage_image] =>[orig_patent_app_number] => 12868457 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/868457
Composition and method for irrigation of a prepared dental root canal Aug 24, 2010 Issued
Array ( [id] => 8612757 [patent_doc_number] => 20130018069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'SUSTAINED RELEASE DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF HEAD AND NECK CANCERS' [patent_app_type] => utility [patent_app_number] => 13/391756 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7617 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391756 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/391756
Sustained release delivery systems for the prevention and treatment of head and neck cancers Aug 24, 2010 Issued
Array ( [id] => 6149988 [patent_doc_number] => 20110021583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'ENHANCED TRANSMUCOSAL COMPOSITION AND DOSAGE FORM' [patent_app_type] => utility [patent_app_number] => 12/860978 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13686 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021583.pdf [firstpage_image] =>[orig_patent_app_number] => 12860978 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/860978
ENHANCED TRANSMUCOSAL COMPOSITION AND DOSAGE FORM Aug 22, 2010 Abandoned
Array ( [id] => 8324442 [patent_doc_number] => 20120196853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'Novel Quinoline-Hepcidine Antagonists' [patent_app_type] => utility [patent_app_number] => 13/390785 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 17726 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390785 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/390785
Novel Quinoline-Hepcidine Antagonists Aug 18, 2010 Abandoned
Array ( [id] => 5977829 [patent_doc_number] => 20110071124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Compounds that Inhibit Production of sAPPB and AB and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/858837 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 96 [patent_figures_cnt] => 96 [patent_no_of_words] => 17290 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071124.pdf [firstpage_image] =>[orig_patent_app_number] => 12858837 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/858837
Compounds that Inhibit Production of sAPPB and AB and Uses Thereof Aug 17, 2010 Abandoned
Array ( [id] => 8503182 [patent_doc_number] => 20120302590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'METHODS AND COMPOSITIONS TO PREVENT ADDICTION' [patent_app_type] => utility [patent_app_number] => 13/389959 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20281 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389959 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/389959
METHODS AND COMPOSITIONS TO PREVENT ADDICTION Aug 12, 2010 Abandoned
Array ( [id] => 8313644 [patent_doc_number] => 20120190668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLEUCLE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/384760 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29133 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384760 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/384760
ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLEUCLE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY Aug 11, 2010 Abandoned
Array ( [id] => 8653229 [patent_doc_number] => 08372978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate' [patent_app_type] => utility [patent_app_number] => 12/851267 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11641 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851267 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/851267
Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate Aug 4, 2010 Issued
Array ( [id] => 8313727 [patent_doc_number] => 20120190751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMPOUNDS FOR TREATMENTS OF INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 13/388174 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9242 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388174 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/388174
COMPOUNDS FOR TREATMENTS OF INFLAMMATION Jul 29, 2010 Abandoned
Array ( [id] => 6000638 [patent_doc_number] => 20110117070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEADACHE' [patent_app_type] => utility [patent_app_number] => 12/844700 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6036 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117070.pdf [firstpage_image] =>[orig_patent_app_number] => 12844700 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/844700
COMPOSITIONS AND METHODS FOR TREATING HEADACHE Jul 26, 2010 Abandoned
Array ( [id] => 8313634 [patent_doc_number] => 20120190648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID' [patent_app_type] => utility [patent_app_number] => 13/386162 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15656 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386162 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/386162
FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID Jul 22, 2010 Abandoned
Array ( [id] => 6007139 [patent_doc_number] => 20110059170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS' [patent_app_type] => utility [patent_app_number] => 12/838364 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12514 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059170.pdf [firstpage_image] =>[orig_patent_app_number] => 12838364 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/838364
Methods for administering weight loss medications Jul 15, 2010 Issued
Array ( [id] => 6449169 [patent_doc_number] => 20100280125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'MEDICINAL AGENT' [patent_app_type] => utility [patent_app_number] => 12/834627 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280125.pdf [firstpage_image] =>[orig_patent_app_number] => 12834627 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/834627
MEDICINAL AGENT Jul 11, 2010 Abandoned
Array ( [id] => 8312557 [patent_doc_number] => 20120189579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'SUBSTITUTED PYRROLIDINONE AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE' [patent_app_type] => utility [patent_app_number] => 13/383042 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19146 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383042 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/383042
SUBSTITUTED PYRROLIDINONE AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE Jul 8, 2010 Abandoned
Menu